Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Blood (2015) 126 (23): 518.

https://doi.org/10.1182/blood.V126.23.518.518

Published: 2015

Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Blood (2015) 126 (23): 2636.

https://doi.org/10.1182/blood.V126.23.2636.2636

Published: 2015

Journal Articles

Long Term Follow up of SWOG S0313: Ibritumomab Tiuxetan Consolidation after 3 Cycles of CHOP Plus Radiotherapy for High Risk Limited Stage Aggressive B-Cell Lymphoma

Daniel O Persky, MD, Thomas P. Miller, MD, Joseph M Unger, PhD, Catherine M. Spier, MD, Soham D. Puvvada, MD, B. Dino Stea, MDPhD, Oliver W. Press, MD PhD, Louis Constine, MD, Kevin Barton, MD, Michael LeBlanc, PhD, Sonali Smith, MD, Richard I. Fisher, MD, Jonathan W. Friedberg, MD

Blood (2014) 124 (21): 4414.

https://doi.org/10.1182/blood.V124.21.4414.4414

Published: 2014

Journal Articles

SWOG S0410/BMT CTN 0703: A Phase II Trial of Tandem Autologous Stem Cell Transplantation (AHCT) for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Eileen P. Smith, MD, Hongli Li, M.S., Jonathan W. Friedberg, MD, Louis Constine, MD, Lisa M. Rimsza, MD, Ginna G. Laport, MD, Leslie L. Popplewell, MD, David G Maloney, MDPhD, Michael Leblanc, PhD, Stephen J. Forman, MD, Richard I. Fisher, MD, Patrick J. Stiff, MD

Blood (2014) 124 (21): 676.

https://doi.org/10.1182/blood.V124.21.676.676

Published: 2014

Journal Articles

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Bouthaina S. Dabaja, MD, Richard Tsang, MD, Shunan Qi, Pamela Allen, PhD, David C. Hodgson, MD, Umberto Ricardi, MD, Richard T. Hoppe, MD, Andrea Ng, Lena Specht, Ye-xiong Li, MD, Stephanie Terezakis, MD, Louis Constine, MD, Joachim Yahalom, MD

Blood (2013) 122 (21): 4292.

https://doi.org/10.1182/blood.V122.21.4292.4292

Published: 2013

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan W. Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Therese Smudzin, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2012) 120 (21): 219.

https://doi.org/10.1182/blood.V120.21.219.219

Published: 2012

Journal Articles

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Cindy Schwartz, MD, MPH, Lu Chen, PhD, Louis Constine, MD, Suzanne Wolden, Frank G Keller, MD, Kara M Kelly, MD, Debra l Friedman, MD, MS

Blood (2011) 118 (21): 3649.

https://doi.org/10.1182/blood.V118.21.3649.3649

Published: 2011

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Jessica DeBolt, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2011) 118 (21): 3295.

https://doi.org/10.1182/blood.V118.21.3295.3295

Published: 2011

Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD

Blood (2010) 116 (21): 766.

https://doi.org/10.1182/blood.V116.21.766.766

Published: 2010

Journal Articles

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Frank G Keller, MD, James Nachman, MD, Louis Constine, MD, John Thomson, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Cindy Schwartz, MD

Blood (2010) 116 (21): 767.

https://doi.org/10.1182/blood.V116.21.767.767

Published: 2010

Journal Articles

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

Jane L. Liesveld, MD, Rui Chen, Joseph Pawlowski, Jessica Debolt, Michael Becker, Louis Constine, Gordon L. Phillips, II, MD, Ollivier Hyrien, Yuhchyau Chen

Blood (2010) 116 (21): 4522.

https://doi.org/10.1182/blood.V116.21.4522.4522

Published: 2010

Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Makiko Ban-Hoefen, MD, Jonathan W. Friedberg, MD, Jennifer L. Kelly, PhD, MPH, Steven H. Bernstein, MD, Jane L. Liesveld, MD, Faith Young, MD, Richard I Fisher, MD, Louis Constine, MD, Michael Becker, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 2393.

https://doi.org/10.1182/blood.V116.21.2393.2393

Published: 2010

Journal Articles

Early Stage Diffuse Large B Cell Lymphoma (DLBCL) in the CHOP-R Era: Does Involved Field Radiation Therapy (IFRT) Impact Outcome?.

Manzurul A. Sikder, MD, Sughosh Dhakal, Jennifer Kelly, MPH, Steven H. Bernstein, MD, Faith Young, MD, Richard I. Fisher, MD, Jonathan Friedberg, MD, Louis Constine, MD

Blood (2007) 110 (11): 3433.

https://doi.org/10.1182/blood.V110.11.3433.3433

Published: 2007

Journal Articles

Long-Term Outcome of Autologous Stem Cell Transplantation (ASCT) for Hodgkin Lymphoma (HL) in the ABVD Therapeutic Era.

Jonathan W. Friedberg, Elizabeth Sensenig, Jennifer Kelly, Jamie Oliva, Louis Constine, Michael Becker, Gordon Phillips, Jane Liesveld, Richard I. Fisher, Steven H. Bernstein

Blood (2007) 110 (11): 1907.

https://doi.org/10.1182/blood.V110.11.1907.1907

Published: 2007

Journal Articles

Patterns and Timing of Initial Relapse in Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma.

Sughosh Dhakal, BS, Tithi Biswas, M.D., Sheema Chawla, M.D., Nikhil Uppal, M.D., Christopher Beck, Ph.D., Sarada Uppuluri, B.S., Jane Liesveld, M.D., Ann Muhs, B.A, Gordon Phillips, M.D., Louis Constine, M.D.

Blood (2006) 108 (11): 3673.

https://doi.org/10.1182/blood.V108.11.3673.3673

Published: 2006

NARROW

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Long Term Follow up of SWOG S0313: Ibritumomab Tiuxetan Consolidation after 3 Cycles of CHOP Plus Radiotherapy for High Risk Limited Stage Aggressive B-Cell Lymphoma

SWOG S0410/BMT CTN 0703: A Phase II Trial of Tandem Autologous Stem Cell Transplantation (AHCT) for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma (HL) (ClinicalTrials.gov Identifier: NCT00233987)

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Early Stage Diffuse Large B Cell Lymphoma (DLBCL) in the CHOP-R Era: Does Involved Field Radiation Therapy (IFRT) Impact Outcome?.

Long-Term Outcome of Autologous Stem Cell Transplantation (ASCT) for Hodgkin Lymphoma (HL) in the ABVD Therapeutic Era.

Patterns and Timing of Initial Relapse in Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only